2C-T
2C-T is a lesser-known psychedelic of the substituted phenethylamine class and a member of the 2C-x family, which are closely related to mescaline. It was first described in the scientific literature by David E. Nichols and Alexander Shulgin in 1976,1 with further detail published in Shulgin's 1991 book PiHKAL.2 Among the 2C psychedelics, 2C-T is notable for its relatively low potency and comparatively short duration of effects.2
Contents
Dosage & Duration
Dosage
Duration
Subjective Effects
2C-T produces a rapid but quiet onset, with effects noticeable within roughly fifteen minutes and developing without dramatic intensity. The experience is unusual among psychedelics in that it feels distinctly psychedelic while producing little to nothing in the way of visual effects; instead it centers on tactile warmth, easy conversation, and an MDMA-like sense of emotional openness, leading some to consider it a possible MDMA substitute. The character has been described as somewhat generic and sharper-edged than 2C-B, with a total duration of roughly five to six hours and a notably relaxed comedown that can pass into deep, dream-filled sleep.
Physical
The body feeling is generally warm and pleasant, with a very relaxed offset. Stomach discomfort or uncertainty can occur, particularly during the come-up.
Cognitive
The headspace combines conversational ease and a sense of things feeling opened up with a consistently reported emotional removal, in which the intellect tends to be more evident than the heart. Some users describe a subtle, transparent sense of separation from their surroundings, and appreciation of poetry may be increased.
Emotional
Tactile
Reagent Testing
Loading reagent data
Pharmacology
Pharmacodynamics
2C-T acts as an agonist at serotonin 5-HT2A and 5-HT2B receptors, with its psychedelic effects primarily attributed to 5-HT2A receptor activity.3 It has also been characterized as a partial agonist at 5-HT2A.3 The compound shows broader affinity for the 5-HT2 receptor family but does not appear to bind monoamine transporters.3 Based on structural similarity to related 2C-T-x compounds, 2C-T may possess some monoamine oxidase inhibitor (MAOI) activity, though this has not been directly established.
Pharmacokinetics
Dangerous
Highest riskThese combinations are considered extremely harmful and should always be avoided. Reactions to these drugs taken in combination are highly unpredictable and have a potential to cause death.
Unsafe
AvoidThere is considerable risk of physical harm when taking these combinations, they should be avoided where possible.
Caution
Use cautionThese combinations are not usually physically harmful, but may produce undesirable effects, such as physical discomfort or overstimulation. Extreme use may cause physical health issues. Synergistic effects may be unpredictable. Care should be taken when choosing to use this combination.
Tolerance
Serotonergic psychedelics
Harm Potential
Addiction & Dependence
Psychological
Extremely Low2C-T is not habit-forming4. With repeated use, the urge to take it may lessen, and use is typically self-limiting.
History & Culture
2C-T emerged from collaborative research between pharmacologist David E. Nichols and chemist Alexander Shulgin, with the compound first appearing in scientific literature in 1976.1 The substance was subsequently documented in greater detail in Shulgin's 1991 book…
Legality
By Country
References
Source Pages
Citations
- (October 1976). Sulfur analogs of psychotomimetic amines. Journal of Pharmaceutical Sciences, 65(10), 1554–1556. https://doi.org/10.1002/jps.260065104012
- Shulgin A, & Shulgin A. (1991). PiHKAL: A Chemical Love Story. Transform Press. https://erowid.org/library/books_online/pihkal/pihkal039.shtml123456
- (n.d.). It is one of the shortest-acting of the 2C psychedelics, as well as among the least [[potency (pharmacology)|potent]].<ref name="PiHKAL" /> The effects of 2C-T have been reported t. https://doi.org/10.1016/j.neuropharm.2017.07.0121234
- Nichols DE. (2016). Psychedelics. Pharmacological Reviews, 68(2), 264–355. https://doi.org/10.1124/pr.115.0114781
- (n.d.). Controlled Drugs and Substances Act — Schedule III, Item 35 (2C-phenethylamines). Justice Laws Website. https://laws-lois.justice.gc.ca/eng/acts/c-38.8/page-11.html12
- (n.d.). Misuse of Drugs Act 1971 — Schedule 2, Part I (Class A drugs). legislation.gov.uk. https://www.legislation.gov.uk/ukpga/1971/38/schedule/2/part/I12
Automated synthesisInformation aggregated and synthesized using an autonomous workflow built by Josie Kins.
Suggest an edit
Spotted a mistake, an outdated claim, or something missing from the 2C-T article? Send the editors a private note. Feedback lands in a moderation queue and is never shown on the site.